Australian entrepreneur, Lauren Barber, turned her nursing background into the role of an inventor and launched a medical device into the Australian healthcare industry.
Lauren began her career as a nurse at the Sydney Adventist Hospital and later moved into cosmetic dermatology, leading her to start her own company. Her journey as an entrepreneur has been challenging, but she has learned skills in resilience and crisis management. She still works as a nurse for 1-2 days a week to maintain her clinical skills. Her inspiration for this career path stems from a personal experience with a needle stick injury that led her to explore the relationship between needle-phobia and a person’s health.
NeedleCalm has now launched a new, world-leading medical device in Australia to improve vaccination rates and calm the nerves of the approximately six million Australians who fear injections. The Class 1 medical device, which recently received approval from the TGA, works by using a technique referred to as “closing the gate” between the needle injection site and pain receptors in the brain.
“Our technology is a game-changer and can be used in an estimated 76 million needle procedures in Australia each year. It’s easy to dismiss needle phobias, but they affect approximately 25% of Australians, while a local study found one in five patients with a fear of needles reported avoiding healthcare.”, says Lauren.
And today in Adelaide at the Australian College of Nursing’s National Nursing Forum, Lauren Barber was awarded the winner of the Health Minister’s Award for Nursing Trailblazers. The award acknowledges nurse-led innovations and models of care which significantly improve health outcomes for the Australian community through evidence-based processes.
With the support of her family and over 10 mentors who specialise in various areas, Lauren has overcome struggles in finance and fundraising. She has learned from her mistakes and now seeks advice from multiple sources before making a decision. In this reflection segment with Australian Health Journal, Lauren talks about the challenges of bringing a medical device to market, not just in company formation, regulatory approvals but also in selling to the health care procurement departments in hospitals.
No journey is linear for an entrepreneur, but Lauren has travelled considerable distance from a nursing student to a successful entrepreneur illustration her determination and passion to help those with needle phobias. Lauren’s work with NeedleCalm is making a positive impact in the healthcare industry and improving the experiences of patients and clinicians alike.
Adapted from Charles Sturt article “Lauren launches world-leading medical device to improve healthcare access”
-
Shaping Health, Advancing Nursing through training, upskilling & scholarships
The Chief Executive Officer of Australian College of Nursing, Adjunct Professor Kylie Ward FACN spoke in depth with Australian Health Journal about:
The key recommendations in ACN’s pre-budget submission to Federal Government
The impact of legislation requiring a Registered Nurse (RN) at every residential aged care facility from 1st July 2023
Why scholarships in nursing leadership are important
Why ACN has recommended the Government fund 200 Pacific nurses in 15 nations for the online ACN postgraduate certification
The need for a multi-pronged approach that includes skilled migration in rebuilding the nursing workforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Nurse recognised for reducing hospital waste
A nurse who started a charity from a granny flat in her parent’s backyard to reduce hospital waste has taken out one of the Australian nursing profession’s most prestigious honours.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
